Phase II study of oxaliplatin, capecitabine, and cetuximab in advanced hepatocellular carcinoma
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Capecitabine; Cetuximab; Oxaliplatin
- Indications Liver cancer
- Focus Therapeutic Use
- 12 Jul 2017 Biomarkers information updated
- 30 Mar 2012 Actual patient number (33) added as reported by ClinicalTrials.gov.
- 30 Mar 2012 Actual end date (1 Dec 2010) added as reported by ClinicalTrials.gov.